Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120

Alamar Biosciences Announces the Launch of the NULISAseq Mouse Panel 120

Providing the largest and most comprehensive, high sensitivity, protein biomarker analysis to advance pre-clinical research FREMONT, Calif., March 24, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the...

Relativity Drives Transformation Across the Legal Industry Through Strategic AI Investments

Relativity Drives Transformation Across the Legal Industry Through Strategic AI Investments

At Legalweek 2025, Relativity showcases the proven impact of aiR, introduces aiR for Review for the public sector and celebrates the legal industry's AI Visionaries CHICAGO, March 24, 2025 /PRNewswire/ -- At Legalweek 2025, global legal technology...

Julius by Triller launch Influencer Marketing Report 2025

Julius by Triller launch Influencer Marketing Report 2025

New report reveals the top influencer marketing strategies shaping the future of brand partnerships LOS ANGELES, March 24, 2025 /PRNewswire/ -- As influencer marketing continues to evolve, brands must adapt to changing audience behaviors and...

Farmmi, Inc. Announces Expansion into the U.S. East Coast Market with New Warehouse in New Jersey

Farmmi, Inc. Announces Expansion into the U.S. East Coast Market with New Warehouse in New Jersey

LISHUI, China, March 24, 2025 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI) today announced that the Company has expanded its U.S. logistics and warehousing operations to the East Coast market. This significant milestone...

Endless Announces Partnership with University of Surrey, Accelerating Web3 and AI Innovations

Endless Announces Partnership with University of Surrey, Accelerating Web3 and AI Innovations

LONDON, March 24, 2025 /PRNewswire/ -- Endless is thrilled to reveal its new partnership with the University of Surrey, marking a significant step forward for the Endless ecosystem. By integrating advanced Web3 solutions with state-of-the-art AI...

Electrolux Group announces industry-leading target in its latest sustainability reporting

Electrolux Group announces industry-leading target in its latest sustainability reporting

STOCKHOLM, March 24, 2025 /PRNewswire/ -- Today Electrolux Group announces a new ambitious recycled materials target, which aims to increase the share of recycled steel and plastic by weight used in the products manufactured by the Group to 35% by...

Seeing Machines announces new technology and safety appointments

Seeing Machines announces new technology and safety appointments

CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Seeing Machines Limited (AIM: SEE, "Seeing Machines" or the "Company"), the advanced computer vision technology company that designs AI-powered operator monitoring systems to improve transport...

ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China

ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China

SHANGHAI, March 24, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of attention deficit hyperactivity...

FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

FuSure Reinsurance Secures Long-Term Insurance Authorization and Upgrades to Composite License from Hong Kong Insurance Authority

HONG KONG, March 24, 2025 /PRNewswire/ -- FuSure Reinsurance ("FuSure") is pleased to announce that, following four years of steady growth, it has successfully secured a long-term insurance authorization (Class A and Class D) from the Hong Kong...

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019

-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Evaluation of SCB-1019 as part of a respiratory...

  • 1
  • ...
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • ...
  • 73
  • menu
    menu